Chrysler
Summary
NHTSA campaign 23V058: Chrysler recalled for a safety defect. An instrument panel display that is not visible to the driver may result in the inability to see safety-critical informa
Details
Source
nhtsa
External ID
23V058
Action Date
2023-02-09
Status
Ongoing
Category
vehicle
Product Description
Chrysler (FCA US, LLC) is recalling certain 2022 Jeep Compass vehicles. The instrument panel center cluster display may be insufficiently illuminated and may not appear visible during daytime driving conditions. As such, these vehicles fail to comply with the requirements of Federal Motor Vehicle Safety Standard number 101, "Control and Displays."
Company
Context & Analysis
Chrysler has 242 FDA actions in our database.
Frequently Asked Questions
How often does Chrysler have FDA actions?
Chrysler has 242 FDA actions in our database, including 0 recalls and 0 device clearances.
Where can I find the official FDA record?
The official record is available on FDA.gov. Use the link above to view the complete official filing. You can also use the openFDA API to query this record programmatically.
Want to know the moment something like this happens?
Get alerts for vehicle